Fig. 1From: Could local surgery improve survival in de novo stage IV breast cancer?Kaplan-Meier curves estimate overall survival in: a. de novo stage IV breast cancer (Median survival was 78Ā months in the surgery group vs. 37Ā months in the no surgery group; log-rank test: pā=ā0.002); b. bone metastasis only (Median survival was 106Ā months in the surgery group vs. 80Ā months in the no surgery group; log-rank test: pā=ā0.172); c. viscera metastasis only (Median survival was 60Ā months in the surgery group vs. 26Ā months in the no surgery group; log-rank test: pā=ā0.249); d. soft tissue metastasis only (Median survival was 136Ā months in the surgery group vs. 21Ā months in the no surgery group; log-rank test: pā=ā0.006)Back to article page